Phase-I-Studie zur Ermittlung der maximal tolerablen Dosis (MTD) von Gemcitabin, Carboplatin und Irinotecan bei unvorbehandelten Patienten mit kleinzelligem Bronchialkarzinom (Extensive Disease)
Year: 2005
Type: article
Study design: Clinical Trial
Source: Pneumologie
Authors: B Wagner, C Kortsik, K Deisenberger
Language: German
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2657288146